These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 2989707)

  • 1. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex.
    Robert-Guroff M; Brown M; Gallo RC
    Nature; 1985 Jul 4-10; 316(6023):72-4. PubMed ID: 2989707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy.
    Aiuti F; Rossi P; Sirianni MC; Carbonari M; Popovic M; Sarngadharan MG; Contu L; Moroni M; Romagnani S; Gallo RC
    Br Med J (Clin Res Ed); 1985 Jul; 291(6489):165-6. PubMed ID: 2990634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
    Casareale D; Dewhurst S; Sonnabend J; Sinangil F; Purtilo DT; Volsky DJ
    AIDS Res; 1984-1985; 1(6):407-21. PubMed ID: 6085926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAV.
    Harada S; Purtilo DT; Koyanagi Y; Yamamoto N
    Microbiol Immunol; 1986; 30(6):533-44. PubMed ID: 3018457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients.
    Weiss RA; Clapham PR; Cheingsong-Popov R; Dalgleish AG; Carne CA; Weller IV; Tedder RS
    Nature; 1985 Jul 4-10; 316(6023):69-72. PubMed ID: 2989706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany.
    Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
    Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS.
    Chang NT; Huang J; Ghrayeb J; McKinney S; Chanda PK; Chang TW; Putney S; Sarngadharan MG; Wong-Staal F; Gallo RC
    Nature; 1985 May 9-15; 315(6015):151-4. PubMed ID: 2986016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
    Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC
    Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III.
    Abb J
    Med Microbiol Immunol; 1985; 174(4):205-10. PubMed ID: 2999573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of clinical spectrum of HTLV-III infection.
    Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K
    Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive assay for neutralizing antibodies against AIDS-related viruses (HTLV-III/LAV).
    Harada S; Purtilo DT; Koyanagi Y; Sonnabend J; Yamamoto N
    J Immunol Methods; 1986 Sep; 92(2):177-81. PubMed ID: 3639115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV-I-specific antibody in AIDS patients and others at risk.
    Robert-Guroff M; Blayney DW; Safai B; Lange M; Gelmann EP; Gutterman JW; Mansell PW; Goedert JL; Groopman JE; Steigbigel NH
    Lancet; 1984 Jul; 2(8395):128-31. PubMed ID: 6146035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
    Goedert JJ; Sarngadharan MG; Biggar RJ; Weiss SH; Winn DM; Grossman RJ; Greene MH; Bodner AJ; Mann DL; Strong DM
    Lancet; 1984 Sep; 2(8405):711-6. PubMed ID: 6148471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS.
    Redfield RR; Markham PD; Salahuddin SZ; Sarngadharan MG; Bodner AJ; Folks TM; Ballou WR; Wright DC; Gallo RC
    JAMA; 1985 Mar; 253(11):1571-3. PubMed ID: 2983127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders.
    Groopman JE; Hartzband PI; Shulman L; Salahuddin SZ; Sarngadharan MG; McLane MF; Essex M; Gallo R
    Blood; 1985 Sep; 66(3):742-4. PubMed ID: 2992644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS.
    Tedder RS; Shanson DC; Jeffries DJ; Cheingsong-Popov R; Clapham P; Dalgleish A; Nagy K; Weiss RA
    Lancet; 1984 Jul; 2(8395):125-8. PubMed ID: 6146034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
    Neurath AR; Strick N; Sproul P; Baker L; Rubinstein P; Stevens CE; Taylor P; Gallo RC; Gold JW; Lee YS
    J Virol Methods; 1985 May; 11(1):75-86. PubMed ID: 2989312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to acquired immune deficiency syndrome (AIDS)-associated virus (HTLV-III/LAV) in Venezuelan populations.
    Volsky DJ; Rodriguez L; Dewhurst S; Sinangil F; Sakai K; Merino F; Esparza B; De Salvo L
    AIDS Res; 1986; 2(2):79-92. PubMed ID: 3013223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology of AIDS: biological and biochemical characteristics of HTLV-III.
    Markham PD; Shaw GM; Salahuddin SZ; Hahn B; Sarngadharan MG; Gallo RC
    Adv Exp Med Biol; 1985; 187():13-34. PubMed ID: 2994417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.